Investment beckons in health care in China
Print Edition
CHINESE demand for better health care quality and structural reform of the sector will offer abundant investment opportunities, a conference in Shanghai heard yesterday.
By 2020, China’s health care market is estimated to grow at a compound annual rate of as much as 20 percent, Richard Yeh, head of China Healthcare Research at Citi Research, told the China Healthcare Investment Conference yesterday.
Zhu Hongren, former chief engineer at the Ministry of Industry and Information Technology, said in a keynote speech that the country’s aging population as well as investors’ enthusiasm for the health care sector are providing new growth potential under China’s new economic scenario.
Norman Chen, venture partner at Fidelity Growth Partners Asia, said he’s seeing a large number of investment opportunities across different sectors including biopharmaceuticals, medical devices and retail.
Lu Hongbo, managing director of OrbiMed, a health care investment firm which oversees US$14 billion of assets globally, said investment will rise in emerging countries in Asia.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
